Three Ways Buying Goes Wrong Without Looking Like a Mistake

Bad buying decisions rarely show up as a single obvious mistake. Nobody orders 10,000 units of something nobody wants and watches it sit. The real damage is quieter than that — it's baked into decisions that each look reasonable in isolation, and only show up as a problem three months later when your GMROI is down and you can't figure out why, because the top-line sales number still looks fine.

Here are three patterns that do exactly that.

Variant and shade proliferation. Every buyer wants to give the customer choice, and in a category like beauty or wellness, more shades or formulations feels like better merchandising. But every new variant splits your inventory dollars and your sell-through data across a wider set of SKUs, without necessarily growing total demand for the category. You end up with twelve shades each selling a trickle instead of four shades each turning fast. The sales report shows the category is "performing" because total units moved look fine in aggregate. What it hides is that your open-to-buy dollars are now spread thin across SKUs that individually can't earn back their shelf space, and your turn rate on the category as a whole is quietly eroding. The fix isn't fewer choices for the sake of it — it's tracking sell-through by SKU, not just by category, and being willing to consolidate variants that aren't independently pulling their weight.

Line overlap. This is the buy that cannibalizes your own portfolio instead of growing it. You add a new product that's close enough to an existing bestseller that customers just substitute one for the other — you haven't grown the pie, you've split it, and now you're carrying inventory dollars in two SKUs instead of concentrating them in the one that actually earns. It's especially easy to miss because both products can show healthy individual sales; nobody notices that the new one grew by roughly the amount the old one shrank. Catching this requires looking at category-level demand, not SKU-level sales, before you commit the buy. If a new item's total addressable customer looks identical to an existing bestseller's, you're not adding revenue, you're just adding carrying cost.

Trend-expired stock holding prime shelf space. This is the most expensive of the three because it's not just a bad buy, it's a bad buy that keeps costing you every day it's not cleared. Inventory that's lost its cultural or seasonal relevance doesn't announce itself — it just sells a little slower every week, and because nobody wants to take the margin hit of marking it down, it sits. Meanwhile it's occupying your best shelf space, the spot that should be earning its keep with something customers actually want right now. The GMROI math on that shelf space isn't just "what did this item earn," it's "what did this item earn relative to what a current, in-demand item would have earned in the same square footage over the same period." Dead stock sitting on prime real estate is a negative number by that math, even if the item technically still sells a few units a month.

All three of these share the same root cause: they're invisible in a top-line sales report and only show up when you look at GMROI, turn rate, and sell-through at the SKU level, not the category level. That's the actual job of the buy — not just picking product people will like, but building an open-to-buy discipline that catches these patterns before they've eaten three months of margin. The buy that looked fine on the order form is where all three of these start.

Copyright © 2026 All Rights Reserved
crossmenuchevron-down